Immune therapy in Type 1 Diabetes aims at detecting the presence of diabetes at a very early stage. This early detection will allow the patient to take proper lifestyle measures and prevent the onset of the disease. Diabetes can only be prevented in the very early stage. Once it is established in the body, it is a lifetime medical condition that requires medication. Diabetes is caused by genetic factors as well as environmental factors. It is for this reason that researchers are now studying the genetic factors that may be responsible for diabetes. They are also studying the assault on Beta cells in the body, which have been touted to be a reliable indicator of the possible onset of Type 1 Diabetes. There has been considerable progress already made towards researching the environmental factors. However, a lot still needs to be done. The focus is to create a vaccine that will help prevent the onset of Type 1 Diabetes after it has been identified at very early stages.

via: Canadian Clinical Trial Network 

Beta cell therapy in Type 1 Diabetes aims at transplanting healthy insulin producing cells in the human body, thereby reversing the onset of Type 1 Diabetes. This can be done either by transplanting insulin producing cells or by transplanting cells that have been reprogrammed to produce insulin. Recently, scientists in Australia have been able to cure the diabetes in a monkey by transplanting insulin producing cells from pigs. This has given a new dimension to the ongoing research. Given the fact that human donor of insulin producing cells will be few and expensive, scientists are trying to find out other sources that can be used for transplanting cells into the human body to make it free of diabetes. Research is also being done to minimize the side effects of this therapy.

via: Canadian Clinical Trial Network

Type 1 Diabetes is not only a chronic medical condition, it is also known to give rise to a host of other medical complications. Some of them are related to the complications of kidneys, eyes, nerves, feet and blood pressure etc. Complications therapy is that branch of Type-1 Diabetes research that tries to ensure that diabetes does not lead to these related conditions. This can be done by starting treatments early ensuring that diabetes cannot cause more damage by inducing more medical conditions in the patient’s body. The interference of diabetes that creates a system of impaired vital organs in the body will be prevented if research in complications therapy has successful outcome.

via: Canadian Clinical Trial Network 

Instead of the blood glucose level being discretely monitored by the patients themselves, research in glucose control suggests the creation of an artificial pancreas. The artificial pancreas will continuously monitor the level of glucose in the blood and will then release insulin accordingly. The automation of the process of administering insulin will lead to a stable blood sugar level. This will almost eliminate the difficulties associated with Type 1 Diabetes. However whether a man-made creation can be programmed to behave like the natural pancreas is yet to be seen. It may require considerable research but the goals are well worth pursuing.

via: Canadian Clinical Trial Network 

Research is also been carried out to create a vaccine that will misguide the pancreas into preventive action. This will ensure pancreas become active, do not get damaged and are, therefore, not dependent on external sources for insulin.

Via: Canadian Clinical Trial Network